Portal:CPTAC

From WikiPathways

(Difference between revisions)
Jump to: navigation, search
(adding assay portal section)
(test edit)
Line 9: Line 9:
}}
}}
-
<div style="float:left; width:73%"> <!-- This width add to the the margin below to equal 99%-->
+
<div style="float:left; width:73%"> <!-- This width add to the the margin below to equal 99% -->
{{{{FULLPAGENAME}}/box-normal
{{{{FULLPAGENAME}}/box-normal

Revision as of 01:18, 12 April 2019

edit  

CPTAC Pathways

Welcome to the CPTAC Pathway Portal

This portal highlights pathway content relevant to the Clinical Proteomic Tumor Analysis Consortium (CPTAC).

The National Cancer Institute, part of the National Institutes of Health, announced the launch of a Clinical Proteomic Tumor Analysis Consortium in August 2011. CPTAC is a comprehensive and coordinated effort to accelerate the understanding of the molecular basis of cancer through the application of robust, quantitative, proteomic technologies and workflows. The overarching goal of CPTAC is to improve our ability to diagnose, treat and prevent cancer. To achieve this goal in a scientifically rigorous manner, the NCI launched CPTAC to systematically identify proteins that derive from alterations in cancer genomes and related biological processes, and provide this data with accompanying assays and protocols to the public.

The pathways included in this portal have been organized into classic cancer hallmark categories, based on the different biological capabilities acquired during the multistep development of human tumors. To read more, see Hallmarks of cancer: the next generation, Hanahan and Weinberg, Cell 2011.

edit  

Cancer Hallmark Categories

Sustaining proliferative signaling

EPO receptor signaling (Homo sapiens)

Image does not exist
EPO receptor signaling
Evading growth suppressors

TGF-beta receptor signaling (Homo sapiens)

Image does not exist
TGF-beta receptor signaling
Activating invasion and metastasis

Focal adhesion: PI3K-Akt-mTOR-signaling (Homo sapiens)

Image does not exist
Focal adhesion: PI3K-Akt-mTOR-signaling
Enabling replicative immortality

Wnt/beta-catenin signaling in leukemia (Homo sapiens)

Image does not exist
Wnt/beta-catenin signaling in leukemia
Inducing angiogenesis

Model for regulation of MSMP expression in cancer cells and its proangiogenic role in ovarian tumors (Homo sapiens)

Image does not exist
Model for regulation of MSMP expression in cancer cells and its proangiogenic role in ovarian tumors
Resisting cell death

Target of rapamycin signaling (Homo sapiens)

Image does not exist
Target of rapamycin signaling
Deregulating cellular energetics

Glycolysis and gluconeogenesis (Homo sapiens)

Image does not exist
Glycolysis and gluconeogenesis
Genome instability and mutation

DNA IR-damage and cellular response via ATR (Homo sapiens)

Image does not exist
DNA IR-damage and cellular response via ATR
Tumor promoting inflammation

IL1 signaling (Homo sapiens)

Image does not exist
IL1 signaling
Avoiding immune destruction

Interferon type I signaling (Homo sapiens)

Image does not exist
Interferon type I signaling
Therapeutics

Interactions between immune cells and microRNAs in tumor microenvironment (Homo sapiens)

Image does not exist
Interactions between immune cells and microRNAs in tumor microenvironment

edit  

Featured Pathways

edit  

Assay Portal

CPTAC also includes an Assay Portal to widely disseminate highly characterized proteomic assays to the global research community, with access to SOPs, reagents, and assay characterization/validation data

Resources

Learn how they incorpated WikiPathways images with custom links on their site.

edit  

Pathway Curation

On this page you see rotating displays of hallmark and featured pathways. Where did these pathways come from? They came from people like you! The CPTAC set of pathways can be edited, fixed and added to using the pathway drawing and annotation tools here at WikiPathways.

Getting Started

Resources

Curation projects

edit  

Useful Links

Personal tools